Form 8-K - Current report:
SEC Accession No. 0000950170-24-133091
Filing Date
2024-12-04
Accepted
2024-12-04 08:45:09
Documents
13
Period of Report
2024-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20241204.htm   iXBRL 8-K 41177
2 EX-99.1 apvo-ex99_1.htm EX-99.1 24059
3 GRAPHIC img237228349_0.jpg GRAPHIC 4584
  Complete submission text file 0000950170-24-133091.txt   195103

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20241204.xsd EX-101.SCH 26037
15 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20241204_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 241524954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)